Prescription ID | TCMF5590 |
Pinyin Name | Tian Meng Kou Fu Ye |
Chinese Name | 甜梦口服液 |
English Name | Tian Meng Oral Liquid |
Function Description | 眩晕, 耳鸣, 不寐, 健忘, 脱发症 |
Indications | Tinnitus disorder, Vertigo disorder, Forgetfulness disorder, Insomnia disorder, Insomnia, Tinnitus, Alopecia, Dizziness |
Disease ICD-11 Category |
SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1)
]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), 健忘 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍,未特指的 ]; MC41 [Tinnitus, 耳鸣 ]; ED70 [Alopecia or hair loss, 脱发 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; |
Human Tissues Associated with Indication | Brain, Heart |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH327 | Eleutherococcus senticosus | 刺五加 | TCMH327 | KR080437 |
TCMH197 | Bombyx mori | 蚕蛾 | TCMH197 | AGIRI001-17 |
TCMH967 | Polygonatum sibiricum | 黄精 | TCMH967 | ITSAH4762-14 |
TCMH426 | Codonopsis pilosula | 党参 | TCMH426 | ITSAL4530-14 |
TCMH1794 | Morus alba | 桑葚 | TCMH1794 | ITSAL1073-14 |
TCMH1803 | Amomum villosum | 砂仁 | TCMH1803 | ITSAD521-14 |
TCMH981 | Astragalus membranaceus | 黄芪 | TCMH981 | ITSAK2981-14 |
TCMH1848 | Crataegus pinnatifida | 山楂 | TCMH1848 | ITSAH1684-14 |
TCMH1186 | Lycium chinense | 枸杞子 | TCMH1186 | ITSAO4545-14 |
TCMH2507 | Epimedium brevicornum | 淫羊藿 | TCMH2507 | AY362429 |
TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH243 | Pericarpium citri reticulatae | 陈皮 | TCMH243 | |
TCMH552 | Rhizoma pinelliae preparata | 法半夏 | TCMH552 | |
TCMH1405 | Strychnos nux-vomica | 马钱子 | TCMH1405 | PPBI045-16 |
TCMH1845 | Dioscorea batatas | 山药 | TCMH1845 | |
TCMH2581 | Alisma orientale | 泽泻 | TCMH2581 | KC573871 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT107 | GRIK2 | Glutamate receptor ionotropic kainate 2 | Ion channel | Q13002 |
TCMT109 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | Ion channel | P42262 |
TCMT110 | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | Ion channel | P48058 |
TCMT111 | GRIK5 | Glutamate receptor ionotropic kainate 5 | Ion channel | Q16478 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT118 | MGAM | Maltase-glucoamylase | Hydrolase | O43451 |
TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT18 | GAA | Lysosomal alpha-glucosidase | Hydrolase | P10253 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT241 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | Ion channel | P36544 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT290 | CHRM5 | Muscarinic acetylcholine receptor M5 | GPCR | P08912 |
TCMT291 | CHRM3 | Muscarinic acetylcholine receptor M3 | GPCR | P20309 |
TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT552 | CHRNA3 | Neuronal acetylcholine receptor subunit alpha-3 | Ion channel | P32297 |
TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT605 | EDNRA | Endothelin receptor ET-A | GPCR | P25101 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT653 | GRM1 | Metabotropic glutamate receptor 1 | GPCR | Q13255 |
TCMT654 | GRM5 | Metabotropic glutamate receptor 5 | GPCR | P41594 |
TCMT655 | GRM2 | Metabotropic glutamate receptor 2 | GPCR | Q14416 |
TCMT656 | GRM3 | Metabotropic glutamate receptor 3 | GPCR | Q14832 |
TCMT657 | GRM4 | Metabotropic glutamate receptor 4 | GPCR | Q14833 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT660 | GRM8 | Metabotropic glutamate receptor 8 | GPCR | O00222 |
TCMT664 | SLC1A1 | Excitatory amino acid transporter 3 | Transporter | P43005 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT807 | SLC22A12 | Solute carrier family 22 member 12 | Transporter | Q96S37 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
Target ID | Target Name |
---|---|
TCMT1175 | Human immunodeficiency virus |
TCMT1178 | Actinomyces viscosus |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1189 | Pseudomonas fluorescens |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1321 | Staphylococcus hominis |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1393 | Vibrio sp. |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CHRM3, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GAA, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD17B1, HSD17B2, KDR, MET, PPARA, SLC1A1, SRC, XDH | 8.06534 |
[BP] GO:0007193 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 | 8.06534 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR | 7.87352 |
[BP] GO:0095500 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 | 6.97605 |
[BP] GO:1903831 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 | 6.97605 |
[BP] GO:0007215 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 6.97605 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.97605 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR | 6.79531 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.60051 |
[BP] GO:0007197 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.41326 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, CYP19A1, CYP1A2, CYP1B1, EDNRA, FABP4, GAA, GRM1, GRM5, GRM8, HSD17B2, IGF1R, MET, MGAM, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TYR | 6.36214 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TOP2A, XDH | 6.31213 |
[BP] GO:0007207 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 5.99491 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.96265 |
[BP] GO:0007188 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 | 5.92952 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP4, FLT3, FUT7, GAA, GLO1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TOP2A, TYR | 5.8628 |
[BP] GO:0007268 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 5.8628 |
[BP] GO:0098916 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 5.8628 |
[BP] GO:0099536 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 5.77752 |
[BP] GO:0099537 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 5.77752 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, CA2, CA7, CHRNA3, CHRNA7, GRIK5, GRM1, GRM3, GRM5, GRM8 | 5.76848 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, CA2, CA7, CHRNA3, CHRNA7, GRIK5, GRM1, GRM3, GRM5, GRM8 | 5.76848 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR | 5.75338 |
[BP] GO:0060078 | None | ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM5 | 5.55725 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TOP2A, XDH | 5.49635 |
[BP] GO:0007187 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 | 5.43862 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC | 5.32747 |
[BP] GO:0007196 | None | GRM1, GRM3, GRM5, GRM8 | 5.2455 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, SRC | 5.05798 |
[BP] GO:0007271 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3 | 4.99824 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC | 4.95716 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TOP2A, XDH | 4.88051 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GAA, GRIK5, GRM1, GRM5, MET, SRC | 4.84155 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GAA, GLO1, PIM1, PPARA, TYR, XDH | 4.69116 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, RORC, SRC, TYR | 4.64294 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, BCL2, CDC25B, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH | 4.61789 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, XDH | 4.57897 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, BCL2, CDC25B, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH | 4.57897 |
[BP] GO:0060079 | None | ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 4.49119 |
[BP] GO:0007216 | None | GRM1, GRM3, GRM5, GRM8 | 4.4801 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.37413 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TOP2A, XDH | 4.33937 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, EDNRA, FLT3, MET, PIM1, SRC, TYR | 4.3224 |
[BP] GO:0007213 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.2543 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA | 4.21026 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC | 4.16176 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC | 4.07244 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, RORC, SRC, TYR | 3.87117 |
[BP] GO:0007154 | None | ADORA1, AXL, BCL2, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 3.81212 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC | 3.81212 |
[BP] GO:0042391 | None | ADORA1, BCL2, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC | 3.81212 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CHRNA7, CYP1A1, CYP1B1, KDR, SRC | 3.79731 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HCAR2, KDR, MET, MMP9, PTPN1, SRC, XDH | 3.76273 |
[BP] GO:0007267 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 3.76184 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, RORC, SRC | 3.74893 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HCAR2, KDR, MET, MMP9, PTPN1, SRC, XDH | 3.74893 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, GAA, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR | 3.70563 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 | 3.68084 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.63646 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC, TOP2A | 3.60887 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TOP2A, TYR | 3.56503 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RORC, SRC | 3.56503 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2 | 3.54743 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, GRM1, GRM3, GRM5, GRM8 | 3.54743 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 3.54743 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 | 3.54743 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 3.54743 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC | 3.51106 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, SRC | 3.43925 |
[BP] GO:0006940 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRNA3 | 3.37807 |
[BP] GO:0023052 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 3.37765 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH | 3.37178 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 | 3.37178 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, SRC | 3.35945 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CHRM5, CYP1A1, FABP3, FLT3, HCAR2, PPARA, RORC, SRC | 3.33623 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC | 3.336 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, FUT7, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, TYR, XDH | 3.31764 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH | 3.29123 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CHRM1, CHRNA7, CSNK2A1, CYP1B1, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH | 3.28675 |
[BP] GO:0006811 | None | CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, CHRNA3, CHRNA7, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 | 3.27843 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC | 3.27131 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC | 3.24055 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GAA, MGAM, MMP1, MMP2, MMP9, SRC, XDH | 3.22521 |
[BP] GO:0042493 | response to drug | AKR1B1, APEX1, AXL, BCL2, CA9, CHRNA3, CHRNA7, CYP1A1, CYP1B1, FABP3, KDR, SRC | 3.19768 |
[BP] GO:2001225 | regulation of chloride transport | CA2, CA7, GRM5 | 3.19768 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.19768 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, APEX1, AXL, BCL2, CA2, CA7, CHRM1, CHRNA3, CSNK2A1, CYP19A1, CYP1B1, GRIK5, GRM5, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SRC | 3.14646 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, MMP2, PPARA, SRC | 3.14062 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EDNRA, FLT3, HSD17B2, KDR, PPARA, SRC, TYR | 3.12544 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GAA, HSD17B1, HSD17B2, TYR, XDH | 3.08872 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CHRNA3, CYP19A1, CYP1A1, CYP1B1, HCAR2, HSD17B1, HSD17B2 | 3.07924 |
[BP] GO:0044057 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRNA3, GAA, GRM1, HCAR2, SLC1A1 | 3.0111 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.85788 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, FABP3, FABP4, GRIK5, GRM1, GRM5, MET | 2.85788 |
[BP] GO:0007200 | None | CHRM1, CHRM2, CHRM3, CHRM5, GRM5 | 2.85418 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH | 2.85396 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 | 2.8448 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH | 2.8448 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH | 2.8448 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, CHRNA3, CHRNA7, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC, TYR | 2.76861 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, AXL, BCL2, CHRNA7, CYP1B1, FLT3, GRM1, KDR, MET, PTPN1, SRC, XDH | 2.72397 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH | 2.6743 |
[BP] GO:1901652 | response to peptide | AKR1B1, APEX1, CHRNA7, FABP3, GRM5, IGF1R, PPARA, SRC | 2.62814 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, AURKB, BCL2, CA2, CHRNA7, CYP1A1, EDNRA, GRM1, MMP2, PPARA, SRC, TYR | 2.61533 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH | 2.58679 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, XDH | 2.58102 |
[BP] GO:0002521 | leukocyte differentiation | AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC | 2.53671 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CDC25B, CHRM1, CHRNA7, CSNK2A1, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1 | 2.48633 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APEX1, BCL2, CHRM1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC | 2.4601 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.45536 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, BCL2, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PTPN1, SRC, XDH | 2.43939 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, AXL, CYP1B1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RORC, SRC | 2.43373 |
[BP] GO:0003008 | None | ADORA1, AKR1B1, BCL2, CHRM1, CHRM3, CHRM5, CHRNA7, CYP1B1, EDNRA, GAA, GRM1, GRM5, GRM8, SRC, TYR | 2.42603 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.42603 |
[BP] GO:0099566 | None | GRM1, GRM5 | 2.42603 |
[BP] GO:0000023 | None | GAA, MGAM | 2.42603 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.42603 |
[BP] GO:1905144 | None | CHRNA3, CHRNA7 | 2.42603 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, CHRNA7, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SRC, TYR | 2.42603 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.42603 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC | 2.41508 |
[BP] GO:0006810 | None | ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, GAA, GRIA2, GRIA4, GRIK5, MGAM, MMP9, PPARA, SLC1A1, SRC, XDH | 2.41508 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.39409 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC | 2.37597 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, PPARA, RORC, SRC, TOP2A | 2.36375 |
[BP] GO:1903522 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, GAA, SLC1A1 | 2.35633 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 2.34209 |
[BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PTPN1, SRC | 2.33328 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.32483 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PTPN1, SRC | 2.30373 |
[BP] GO:0097237 | cellular response to toxic substance | AKR1B1, APEX1, AXL, CYP1B1, KDR | 2.30247 |
[BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1 | 2.28995 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD17B1, HSD17B2 | 2.28995 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, FLT3, GRM1, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH | 2.25055 |
[BP] GO:0043393 | regulation of protein binding | AURKB, BCL2, MET, MMP9, PPARA, SRC | 2.22635 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.21788 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA3, CA2, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, GRM1, GRM3, GRM5, GRM8, HCAR2, SRC | 2.21638 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MET, PPARA | 2.20563 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, KDR, SRC | 2.20204 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.18595 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.17992 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, FUT7, GAA, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TOP2A, TYR, XDH | 2.17984 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC | 2.17503 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PTPN1, SRC | 2.16344 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, FLT3, GRM1, GRM5, PTPN1, SRC | 2.15115 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, GLO1 | 2.119 |
[BP] GO:0051234 | None | ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FABP3, GAA, GRIA2, GRIA4, GRIK5, MGAM, MMP9, PPARA, SLC1A1, SRC, XDH | 2.10234 |
[BP] GO:0035235 | None | GRIA2, GRIA4, GRIK5 | 2.09338 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, FLT3, GRM1, KDR, MET, MMP9, PTPN1, SRC, XDH | 2.08752 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, AURKB, CSNK2A1, CYP1B1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC | 2.08417 |
[BP] GO:1900543 | None | EDNRA, GRM3, GRM8, PPARA | 2.08417 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PTPN1, SRC | 2.0803 |
[BP] GO:0048731 | system development | ACHE, ADORA1, ALPL, CHRM1, CHRM2, CHRM3, CHRNA3, EDNRA, MMP9, SRC | 2.07944 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, EDNRA, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MMP9, PTPN1, SRC, XDH | 2.07469 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | CHRM5, FABP3, FLT3, SRC | 2.07207 |
[BP] GO:0045980 | None | EDNRA, GRM3, GRM8, PPARA | 2.07207 |
[BP] GO:0050789 | regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FABP3, FABP4, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, XDH | 2.06719 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, FABP4, FLT3, GRM1, GRM5, IGF1R, PTPN1, SRC | 2.05558 |
[BP] GO:0046541 | None | CHRM1, CHRM3 | 2.01778 |
[CC] GO:0098590 | plasma membrane region | ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, MGAM, SLC1A1, SRC | 8.06534 |
[CC] GO:0097060 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.76685 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, EDNRA, FLT3, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, MGAM, MMP2, PIM1, PTPN1, SLC1A1, SRC | 6.79531 |
[CC] GO:0044456 | None | ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC | 6.41326 |
[CC] GO:0045211 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM3 | 5.99491 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MGAM, SLC1A1, SRC | 5.1191 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, FUT7, GAA, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KDR, MET, MGAM, MMP2, PIM1, PTPN1, SLC1A1, SRC, TYR | 4.80754 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 | 4.40726 |
[CC] GO:0014069 | None | ADORA1, CHRM1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC | 4.13988 |
[CC] GO:0099572 | None | ADORA1, CHRM1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC | 4.13988 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 | 4.0314 |
[CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, KDR, MET, MGAM, PTPN1, SLC1A1, SRC, TYR | 3.70563 |
[CC] GO:0043005 | None | ADORA1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC | 3.54743 |
[CC] GO:0042734 | None | GRIK5, GRM1, GRM3, GRM5, GRM8 | 3.47326 |
[CC] GO:0098802 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1 | 2.53913 |
[CC] GO:0120025 | None | ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SRC | 2.16712 |
[CC] GO:0043235 | receptor complex | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, IGF1R | 2.08752 |
[CC] GO:0030425 | None | CHRM1, CHRM2, CHRM3, CHRNA3, GRIA2, GRIK5, GRM1 | 2.01708 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.4179 |
[MF] GO:0030594 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM5 | 9.23771 |
[MF] GO:0008066 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 8.06534 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC | 8.06534 |
[MF] GO:0046914 | transition metal ion binding | ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH | 7.65201 |
[MF] GO:0015464 | None | CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7 | 7.47364 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET | 7.37037 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET | 7.37037 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, FLT3, FUT7, GAA, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MGAM, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TOP2A, TYR, XDH | 7.31465 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC | 7.31465 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC | 7.05582 |
[MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.92408 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, CHRNA3, CHRNA7, EDNRA, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARA, RORC | 6.6365 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.41326 |
[MF] GO:0016907 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.41326 |
[MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 | 5.42728 |
[MF] GO:0004629 | None | ADORA1, CHRM1, CHRM3, CHRM5, EDNRA | 4.79458 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A | 4.65514 |
[MF] GO:0043167 | ion binding | ACHE, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TOP2A, TYR, XDH | 4.59767 |
[MF] GO:0042166 | None | ACHE, CHRM3, CHRNA3, CHRNA7 | 4.15683 |
[MF] GO:0042562 | hormone binding | ACHE, CHRM3, CHRNA3, CHRNA7, HSD17B1, IGF1R | 4.0314 |
[MF] GO:0005231 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 3.88162 |
[MF] GO:0008081 | None | ADORA1, APEX1, CHRM1, CHRM3, CHRM5, EDNRA | 3.87117 |
[MF] GO:0098960 | None | CHRNA3, CHRNA7, GRM1, GRM5 | 3.81762 |
[MF] GO:0022824 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 3.81762 |
[MF] GO:0022835 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 3.81762 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.70563 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.53251 |
[MF] GO:0043169 | cation binding | ACHE, ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, TOP2A, TYR, XDH | 3.4898 |
[MF] GO:0004435 | None | CHRM1, CHRM3, CHRM5, EDNRA | 3.47584 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC | 3.47326 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.47326 |
[MF] GO:0042578 | None | ADORA1, ALPL, APEX1, CDC25B, CHRM1, CHRM3, CHRM5, EDNRA, PTPN1 | 3.31764 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH | 3.2291 |
[MF] GO:0005230 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 3.14062 |
[MF] GO:0016788 | None | ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, EDNRA, PTPN1 | 3.1085 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.04517 |
[MF] GO:0099528 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 2.97668 |
[MF] GO:0005506 | iron ion binding | ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 2.71835 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.71104 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 2.69331 |
[MF] GO:0004620 | None | ADORA1, CHRM1, CHRM3, CHRM5, EDNRA | 2.55967 |
[MF] GO:0004930 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, EDNRA, GRM1, GRM3, GRM5, GRM8, HCAR2 | 2.54398 |
[MF] GO:0042165 | neurotransmitter binding | ACHE, CHRM3, CHRNA3, CHRNA7 | 2.48888 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.4556 |
[MF] GO:0004970 | None | GRIA2, GRIA4, GRIK5 | 2.42603 |
[MF] GO:0005234 | None | GRIA2, GRIA4, GRIK5 | 2.42603 |
[MF] GO:0032450 | None | GAA, MGAM | 2.42603 |
[MF] GO:0099583 | None | GRM1, GRM5 | 2.42603 |
[MF] GO:0008227 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 2.38415 |
[MF] GO:0016298 | None | ADORA1, CHRM1, CHRM3, CHRM5, EDNRA | 2.20228 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC | 2.1903 |
[MF] GO:0004971 | None | GRIA2, GRIA4 | 2.18595 |
[MF] GO:0004558 | None | GAA, MGAM | 2.18595 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC | 2.13451 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, HSD17B1, HSD17B2, XDH | 2.09338 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC | 2.07744 |
[MF] GO:0015276 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 2.07207 |
[MF] GO:0022834 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 2.07207 |
[MF] GO:0070405 | ammonium ion binding | ACHE, CHRM3, CHRNA3, CHRNA7 | 2.05596 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, GRIA2, CHRM3, CHRNA3, CHRM1, CHRNA7, GRIK5, CHRM5, GRM1, GRM3, GRM5, EDNRA, ADORA3, GRM8, ADORA1, GRIA4 | 13.4684 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 11.5381 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 8.0387 |
Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE, CHRM3, CHRNA3, CHRM1, CHRNA7, CHRM5, BCL2 | 7.1391 |
Glutamatergic synapse_Homo sapiens_hsa04724 | GRM3, GRIA2, GRM5, GRIK5, GRM8, SLC1A1, GRM1, GRIA4 | 7.1391 |
Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, CHRM3, GRM5, EDNRA, CHRM1, CHRNA7, CHRM5, GRM1 | 5.7279 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 6.1964 |
cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, HCAR2, GRIA2, EDNRA, CHRM1, ADORA1, PPARA, GRIA4 | 5.451 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1, SRC, MET, IGF1R | 4.2982 |
Metabolic pathways_Homo sapiens_hsa01100 | MGAM, GAA, AKR1B1, TYR, CYP19A1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, XDH | 3.5474 |
Pathways in cancer_Homo sapiens_hsa05200 | EDNRA, FLT3, MMP1, MMP2, BCL2, MMP9, MET, IGF1R | 3.4425 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, IGF1R | 3.3702 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.9763 |
Galactose metabolism_Homo sapiens_hsa00052 | MGAM, AKR1B10, GAA, AKR1B1 | 4.4458 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.2086 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, GRM1 | 2.7222 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | BCL2, PIM1, CYP1B1, MMP9, MET, CDC25B | 2.6643 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | GRIA2, GRM5, GRM1, GRIA4 | 2.7131 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | CHRNA7, CYP1A2, CYP1A1, CYP1B1 | 2.9702 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, BCL2, MET, IGF1R | 2.575 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, CHRM1, KDR, BCL2, MET, IGF1R | 2.4035 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM3, CHRM1, SRC, CHRM5 | 2.4795 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | GRM3, GRM5, GRM8, GRM1 | 2.2421 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1 | 2.7222 |
Nicotine addiction_Homo sapiens_hsa05033 | GRIA2, CHRNA7, GRIA4 | 2.7222 |
Long-term depression_Homo sapiens_hsa04730 | GRIA2, GRM1, IGF1R | 2.3161 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2, BCL2, PIM1 | 1.7719 |
Long-term potentiation_Homo sapiens_hsa04720 | GRIA2, GRM5, GRM1 | 2.2279 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.9473 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, KDR, MET, IGF1R | 1.7406 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | CYP1A2, CYP1A1, CYP1B1 | 2.1167 |
Gap junction_Homo sapiens_hsa04540 | GRM5, SRC, GRM1 | 1.9274 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.4791 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.6133 |
Hepatitis B_Homo sapiens_hsa05161 | SRC, BCL2, MMP9 | 1.4148 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | EDNRA, ADORA3, ADORA1 | 1.3257 |
Ras signaling pathway_Homo sapiens_hsa04014 | KDR, MET, IGF1R | 1.0901 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1 | 1.3576 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.3529 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.3257 |
Prostate cancer_Homo sapiens_hsa05215 | BCL2, IGF1R | 1.1034 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 1.0933 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 0.9714 |
Taste transduction_Homo sapiens_hsa04742 | CHRM3, GRM1 | 1.1515 |
Starch and sucrose metabolism_Homo sapiens_hsa00500 | MGAM, GAA | 1.3576 |
Amphetamine addiction_Homo sapiens_hsa05031 | GRIA2, GRIA4 | 1.2842 |
Gastric acid secretion_Homo sapiens_hsa04971 | CHRM3, CA2 | 1.2282 |
Melanoma_Homo sapiens_hsa05218 | MET, IGF1R | 1.2537 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 1.0705 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET | 1.2842 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3342 |
Circadian entrainment_Homo sapiens_hsa04713 | GRIA2, GRIA4 | 1.0811 |
Cocaine addiction_Homo sapiens_hsa05030 | GRM3, GRIA2 | 1.4262 |
Renin secretion_Homo sapiens_hsa04924 | EDNRA, ADORA1 | 1.2953 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | BCL2, IGF1R | 1.0382 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PPARA | 1.0074 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2 | 1.0901 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.1936 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1 | 1.2917 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | GRIA2, BCL2 | 1.4145 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.2806 |
Pancreatic secretion_Homo sapiens_hsa04972 | CHRM3, CA2 | 1.0798 |
Dopaminergic synapse_Homo sapiens_hsa04728 | GRIA2, GRIA4 | 0.9031 |
FoxO signaling pathway_Homo sapiens_hsa04068 | GRM1, IGF1R | 0.8861 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2 | 0.9654 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, PIM1 | 0.787 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.9654 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.8589 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, BCL2 | 0.6538 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.7279 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.2557 |
Viral carcinogenesis_Homo sapiens_hsa05203 | SRC | 0.3175 |
Huntington's disease_Homo sapiens_hsa05016 | GRM5 | 0.3332 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3404 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.3533 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.3633 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.3401 |
Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.4089 |
Measles_Homo sapiens_hsa05162 | CSNK2A1 | 0.4104 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.4325 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.398 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1 | 0.4089 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.3946 |
Lysosome_Homo sapiens_hsa04142 | GAA | 0.4325 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | BCL2 | 0.4325 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC | 0.3825 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4426 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | IGF1R | 0.4089 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.4089 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC | 0.4325 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.4148 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.4325 |
AMPK signaling pathway_Homo sapiens_hsa04152 | IGF1R | 0.4325 |
Vascular smooth muscle contraction_Homo sapiens_hsa04270 | EDNRA | 0.4325 |
Cell cycle_Homo sapiens_hsa04110 | CDC25B | 0.4325 |
Serotonergic synapse_Homo sapiens_hsa04726 | ALOX5 | 0.4399 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC | 0.4893 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4275 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.4701 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4701 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC | 0.4735 |
Insulin secretion_Homo sapiens_hsa04911 | CHRM3 | 0.4893 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | IGF1R | 0.4811 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4893 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4893 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4811 |
Small cell lung cancer_Homo sapiens_hsa05222 | BCL2 | 0.4893 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.4893 |
Salivary secretion_Homo sapiens_hsa04970 | CHRM3 | 0.4893 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.4893 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4893 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4893 |
Protein digestion and absorption_Homo sapiens_hsa04974 | SLC1A1 | 0.4893 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC | 0.5319 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6511 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5339 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | IGF1R | 0.5488 |
Glioma_Homo sapiens_hsa05214 | IGF1R | 0.5488 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5476 |
Bile secretion_Homo sapiens_hsa04976 | CA2 | 0.533 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2 | 0.5349 |
Colorectal cancer_Homo sapiens_hsa05210 | BCL2 | 0.5488 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.5488 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5488 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.7392 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5 | 0.5488 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9566 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6319 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | MGAM | 0.6538 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.6523 |
Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.6934 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.7373 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7762 |
Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.756 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | CYP1A2 | 0.787 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8207 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.7844 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8108 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.0709 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 1.0311 |